JP Morgan Chase’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-54
Closed -$92 7914
2024
Q3
$92 Sell
54
-1,872
-97% -$5.7K ﹤0.01% 7013
2024
Q2
$5.37K Buy
1,926
+711
+59% +$2.22K ﹤0.01% 6372
2024
Q1
$5.86K Sell
1,215
-488
-29% -$4.1K ﹤0.01% 6425
2023
Q4
$25.5K Sell
1,703
-52,795
-97% -$2.19M ﹤0.01% 6195
2023
Q3
$3.47M Buy
54,498
+174
+0.3% +$12.2K ﹤0.01% 3109
2023
Q2
$5.07M Buy
54,324
+438
+0.8% +$38.6K ﹤0.01% 2848
2023
Q1
$4.32M Buy
53,886
+371
+0.7% +$43.4K ﹤0.01% 2949
2022
Q4
$5.86M Sell
53,515
-23,770
-31% -$3.55M ﹤0.01% 2691
2022
Q3
$16.4M Buy
77,285
+597
+0.8% +$121K ﹤0.01% 1727
2022
Q2
$8.35M Buy
76,688
+5,833
+8% +$1M ﹤0.01% 2313
2022
Q1
$15.9M Buy
70,855
+57,758
+441% +$12M ﹤0.01% 1961
2021
Q4
$3.02M Buy
+13,097
New +$3.12M ﹤0.01% 3490

Other funds holding CMAX

JP Morgan Chase's CMAX Position: Q4 2024 in Review

JP Morgan Chase sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q4 2024, closing a stake of 54 shares — an estimated $92 sold.

JP Morgan Chase first reported a position in CMAX in Q4 2021 and held it in 12 quarters. The position peaked at $16.4M in Q3 2022. 4 funds tracked by Wall St. Rank hold CMAX as of Q4 2024.

  • JP Morgan Chase reported no remaining CareMax, Inc. Class A Common Stock position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 54 CareMax, Inc. Class A Common Stock shares in Q4 2024, an estimated $92.
  • JP Morgan Chase first reported a position in CareMax, Inc. Class A Common Stock in Q4 2021 and held it in 12 quarters.
  • JP Morgan Chase's CareMax, Inc. Class A Common Stock position peaked at $16.4M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.